Cargando…

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients

BACKGROUND: Mucin-1 (MUC1, CD227), more widely known as CA15-3, is an abundantly expressed epithelial cell surface antigen and has evolved to be the most predictive serum tumour marker in breast cancer. PankoMab-GEX™, which is currently being evaluated for its therapeutic efficacy in a phase IIb cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heublein, Sabine, Mayr, Doris, Egger, Markus, Karsten, Uwe, Goletz, Steffen, Angele, Martin, Gallwas, Julia, Jeschke, Udo, Ditsch, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447018/ https://www.ncbi.nlm.nih.gov/pubmed/25986064 http://dx.doi.org/10.1186/s13046-015-0152-7

Ejemplares similares

Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways
por: Heublein, Sabine, et al.
Publicado: (2015)

Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
por: Heublein, Sabine, et al.
Publicado: (2017)

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
por: Lenhard, Miriam, et al.
Publicado: (2012)

Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology
por: Weissenbacher, Tobias, et al.
Publicado: (2013)

Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
por: Lenhard, Miriam, et al.
Publicado: (2013)

Gex, Mardi
Publicado: (2004)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
por: Scholz, Christoph, et al.
Publicado: (2012)

Extracapsular Lymph Node Involvement in Ovarian Carcinoma
por: Heublein, Sabine, et al.
Publicado: (2019)

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
por: Ditsch, Nina, et al.
Publicado: (2020)

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
por: Heublein, Sabine, et al.
Publicado: (2013)

The G-Protein Coupled Estrogen Receptor (GPER/GPR30) is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients
por: Heublein, Sabine, et al.
Publicado: (2013)

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
por: Tremmel, Eileen, et al.
Publicado: (2019)

Meeting with the Sub-Prefect of Gex
Publicado: (1985)

MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
por: Eppich, Simon, et al.
Publicado: (2020)

MSX1-expression during the different phases in healthy human endometrium
por: Eppich, Simon, et al.
Publicado: (2023)

A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options
por: Eisner, Florian, et al.
Publicado: (2015)

The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors
por: Heublein, Sabine, et al.
Publicado: (2014)

What makes cancer stem cell markers different?
por: Karsten, Uwe, et al.
Publicado: (2013)

Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours
por: Fiedler, Walter, et al.
Publicado: (2018)

The Pays de Gex celebrates science
por: CERN Bulletin
Publicado: (2010)

Histoire du pays de Gex
por: Malgouverné, Alexandre, et al.
Publicado: (1986)

Aerial view of the countryside around Gex.
por: Jean-Luc Caron
Publicado: (1996)

Aerial view of the countryside around Gex.
por: Jean-Luc Caron
Publicado: (1996)

Aerial view of Pays de Gex
por: Jean-Luc Caron
Publicado: (1996)

Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
por: Lenhard, Miriam, et al.
Publicado: (2012)

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
por: Heublein, Sabine, et al.
Publicado: (2013)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

Internationally Oriented Education in the Pays de Gex
Publicado: (1982)

Le Coeur du Pays de Gex
Publicado: (2005)

Expression of GEX1 Orthologs of Brassica rapa and Oryza sativa Rescued the Nuclear Fusion Defect of the Arabidopsis GEX1 Mutant
por: Yabe, Ayaka, et al.
Publicado: (2022)

Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression
por: Weissenbacher, Tobias, et al.
Publicado: (2013)

L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of G(i)- Protein- Coupled Receptors
por: Tremmel, Eileen, et al.
Publicado: (2020)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
por: Fraungruber, Patricia, et al.
Publicado: (2021)

Exposition : Sciences Gex (CERN-VIDEO-M-53)
por: CERN. Geneva. Audiovisual Unit
Publicado: (1993)

"Exposciences" à Gex (CERN-VIDEO-M-57)
por: CERN. Geneva. Audiovisual Unit
Publicado: (1993)

Aerial view of the Pays de Gex to locate LEP
Publicado: (1981)

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
por: Semmlinger, Anna, et al.
Publicado: (2018)

Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival()
por: Sixou, Sophie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nj4o7penlaup170f8jtm29dtm5